Active — Not RecruitingNot Applicable

AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS

Austria, Belgium800 participantsStarted 2024-12-10

Plain-language summary

AI ECG TIMI is an investigator-initiated, international, and multicenter registry of acute coronary syndrome patients aimed to identify electrocardiographic findings detected by an AI model predicting coronary blood flow alteration. The aim of the study is to identify electrocardiographic findings detected by an automated artificial intelligence (AI) model that can predict coronary blood flow alteration as assessed by the TIMI grade flow at the very moment of the invasive coronary angiography in patients with acute coronary syndromes.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with acute coronary syndromes undergoing invasive coronary angiography as clinically indicated. * Availability of a standard 12-lead ECG performed at invasive coronary angiogram before percutaneous coronary intervention (maximum within 15 min before vascular access). * Age ≥18 years. Exclusion Criteria: * Individuals presenting for a non-emergent (elective) cardiac catheterization. * Individuals presenting with chronic coronary syndrome (CCS) or stable angina symptoms. * Individuals without symptoms suspicious for acute coronary syndromes. * Individuals with contraindications for cardiac catheterization.

What they're measuring

Diagnostic Accuracy of the AI-ECG TIMI AI Model

Timeframe: Index hospitalization (assessed up to 5 days)

Trial details

NCT IDNCT06528821

SponsorPowerful Medical

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-03-16

View on ClinicalTrials.gov More Acute Coronary Syndrome trials